Innerva Pharmaceuticals
Innerva Pharmaceuticals is an ophthalmic startup developing a first-in-class pharmacological blockade of PIEZO2 ion channels in ocular surface nerve endings. The company focuses on creating neuromodulators to treat ocular surface pain. Its lead drug candidates target patients suffering from chronic ocular pain and related ophthalmic conditions.
Visit websiteBarcelona, Spain
Biotechnology
Ophthalmology
Pharmaceuticals
Healthtech
Funding summary
- Total raised
- €2.3M
- Funding rounds
- 1
Investors in Innerva Pharmaceuticals
Investors on record for Innerva Pharmaceuticals. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Innerva Pharmaceuticals?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors